Clinical response in patients with ovarian cancer treated with metronomic chemotherapy

Ovarian cancer (OC) is the leading cause of death from gynaecological cancer. It is extremely hard to diagnose in the early stages and around 70% of patients present with advanced disease. Metronomic chemotherapy (MCT) is described as the chronic administration of, generally low, equally spaced, dos...

Descripción completa

Detalles Bibliográficos
Autores: Perroud, Herman Andrés, Scharovsky, Olga Graciela, Rozados, Viviana Rosa, Alasino, Carlos
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2017
País:Argentina
Institución:Consejo Nacional de Investigaciones Científicas y Técnicas
Repositorio:CONICET Digital (CONICET)
Idioma:inglés
OAI Identifier:oai:ri.conicet.gov.ar:11336/179068
Acceso en línea:http://hdl.handle.net/11336/179068
Access Level:acceso abierto
Palabra clave:OVARIAN CANCER
METRONOMIC CHEMOTHERAPY
CYCLOPHOSPHAMIDE
https://purl.org/becyt/ford/1.6
https://purl.org/becyt/ford/1
id AR_b1779bfaa453776b00d2fc15f55a4e49
oai_identifier_str oai:ri.conicet.gov.ar:11336/179068
network_acronym_str AR
network_name_str Argentina
repository_id_str
spelling Clinical response in patients with ovarian cancer treated with metronomic chemotherapyPerroud, Herman AndrésScharovsky, Olga GracielaRozados, Viviana RosaAlasino, CarlosOVARIAN CANCERMETRONOMIC CHEMOTHERAPYCYCLOPHOSPHAMIDEhttps://purl.org/becyt/ford/1.6https://purl.org/becyt/ford/1Ovarian cancer (OC) is the leading cause of death from gynaecological cancer. It is extremely hard to diagnose in the early stages and around 70% of patients present with advanced disease. Metronomic chemotherapy (MCT) is described as the chronic administration of, generally low, equally spaced, doses of chemotherapeutic drugs with therapeutic efficacy and low toxicity. This is an effective and low-cost way to treat several types of tumours, including ovarian cancer. Here, we present six cases of advanced ovarian cancer treated with MCT with low doses of cyclophosphamide, which showed clinical response and stable disease.Fil: Perroud, Herman Andrés. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Rosario; Argentina. Universidad Nacional de Rosario. Facultad de Ciencias Medicas. Instituto de Genetica Experimental; Argentina. Instituto Universidad Italiano de Rosario; ArgentinaFil: Scharovsky, Olga Graciela. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Rosario; Argentina. Universidad Nacional de Rosario. Facultad de Ciencias Medicas. Instituto de Genetica Experimental; Argentina. Universidad Nacional de Rosario. Consejo de Investigaciones de la Universidad de Rosario; ArgentinaFil: Rozados, Viviana Rosa. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Rosario; Argentina. Universidad Nacional de Rosario. Facultad de Ciencias Medicas. Instituto de Genetica Experimental; ArgentinaFil: Alasino, Carlos. Instituto de Oncología de Rosario; Argentina. Instituto Universidad Italiano de Rosario; ArgentinaCancer Intelligence2017-03info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/179068Perroud, Herman Andrés; Scharovsky, Olga Graciela; Rozados, Viviana Rosa; Alasino, Carlos; Clinical response in patients with ovarian cancer treated with metronomic chemotherapy; Cancer Intelligence; Ecancermedicalscience; 11; 723; 3-2017; 1-101754-6605CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/doi/ 10.3332/ecancer.2017.723info:eu-repo/semantics/altIdentifier/url/https://ecancer.org/en/journal/article/723-clinical-response-in-patients-with-ovarian-cancer-treated-with-metronomic-chemotherapyinfo:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2024-05-08T13:43:41Zoai:ri.conicet.gov.ar:11336/179068instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982024-05-08 13:43:41.965CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv Clinical response in patients with ovarian cancer treated with metronomic chemotherapy
title Clinical response in patients with ovarian cancer treated with metronomic chemotherapy
spellingShingle Clinical response in patients with ovarian cancer treated with metronomic chemotherapy
Perroud, Herman Andrés
OVARIAN CANCER
METRONOMIC CHEMOTHERAPY
CYCLOPHOSPHAMIDE
https://purl.org/becyt/ford/1.6
https://purl.org/becyt/ford/1
title_short Clinical response in patients with ovarian cancer treated with metronomic chemotherapy
title_full Clinical response in patients with ovarian cancer treated with metronomic chemotherapy
title_fullStr Clinical response in patients with ovarian cancer treated with metronomic chemotherapy
title_full_unstemmed Clinical response in patients with ovarian cancer treated with metronomic chemotherapy
title_sort Clinical response in patients with ovarian cancer treated with metronomic chemotherapy
dc.creator.none.fl_str_mv Perroud, Herman Andrés
Scharovsky, Olga Graciela
Rozados, Viviana Rosa
Alasino, Carlos
author Perroud, Herman Andrés
author_facet Perroud, Herman Andrés
Scharovsky, Olga Graciela
Rozados, Viviana Rosa
Alasino, Carlos
author_role author
author2 Scharovsky, Olga Graciela
Rozados, Viviana Rosa
Alasino, Carlos
author2_role author
author
author
dc.subject.none.fl_str_mv OVARIAN CANCER
METRONOMIC CHEMOTHERAPY
CYCLOPHOSPHAMIDE
https://purl.org/becyt/ford/1.6
https://purl.org/becyt/ford/1
topic OVARIAN CANCER
METRONOMIC CHEMOTHERAPY
CYCLOPHOSPHAMIDE
https://purl.org/becyt/ford/1.6
https://purl.org/becyt/ford/1
description Ovarian cancer (OC) is the leading cause of death from gynaecological cancer. It is extremely hard to diagnose in the early stages and around 70% of patients present with advanced disease. Metronomic chemotherapy (MCT) is described as the chronic administration of, generally low, equally spaced, doses of chemotherapeutic drugs with therapeutic efficacy and low toxicity. This is an effective and low-cost way to treat several types of tumours, including ovarian cancer. Here, we present six cases of advanced ovarian cancer treated with MCT with low doses of cyclophosphamide, which showed clinical response and stable disease.
publishDate 2017
dc.date.none.fl_str_mv 2017-03
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/179068
Perroud, Herman Andrés; Scharovsky, Olga Graciela; Rozados, Viviana Rosa; Alasino, Carlos; Clinical response in patients with ovarian cancer treated with metronomic chemotherapy; Cancer Intelligence; Ecancermedicalscience; 11; 723; 3-2017; 1-10
1754-6605
CONICET Digital
CONICET
url http://hdl.handle.net/11336/179068
identifier_str_mv Perroud, Herman Andrés; Scharovsky, Olga Graciela; Rozados, Viviana Rosa; Alasino, Carlos; Clinical response in patients with ovarian cancer treated with metronomic chemotherapy; Cancer Intelligence; Ecancermedicalscience; 11; 723; 3-2017; 1-10
1754-6605
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/doi/ 10.3332/ecancer.2017.723
info:eu-repo/semantics/altIdentifier/url/https://ecancer.org/en/journal/article/723-clinical-response-in-patients-with-ovarian-cancer-treated-with-metronomic-chemotherapy
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
application/pdf
application/pdf
dc.publisher.none.fl_str_mv Cancer Intelligence
publisher.none.fl_str_mv Cancer Intelligence
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1799195110463766528
score 15.811543

Similares en LA Referencia